LakeShore Biopharma (LSB) Competitors $0.99 -0.03 (-2.75%) As of 07/3/2025 02:05 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock LSB vs. XCUR, EGRX, ELYM, ABVC, LVTX, ESLA, LTRN, PLUR, OKUR, and XLOShould you be buying LakeShore Biopharma stock or one of its competitors? The main competitors of LakeShore Biopharma include Exicure (XCUR), Eagle Pharmaceuticals (EGRX), Eliem Therapeutics (ELYM), ABVC BioPharma (ABVC), LAVA Therapeutics (LVTX), Estrella Immunopharma (ESLA), Lantern Pharma (LTRN), Pluri (PLUR), OnKure Therapeutics (OKUR), and Xilio Therapeutics (XLO). These companies are all part of the "pharmaceutical products" industry. LakeShore Biopharma vs. Its Competitors Exicure Eagle Pharmaceuticals Eliem Therapeutics ABVC BioPharma LAVA Therapeutics Estrella Immunopharma Lantern Pharma Pluri OnKure Therapeutics Xilio Therapeutics LakeShore Biopharma (NASDAQ:LSB) and Exicure (NASDAQ:XCUR) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, media sentiment, valuation, institutional ownership, earnings and dividends. Do insiders and institutionals have more ownership in LSB or XCUR? 52.6% of LakeShore Biopharma shares are held by institutional investors. Comparatively, 42.8% of Exicure shares are held by institutional investors. 3.9% of Exicure shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has stronger valuation & earnings, LSB or XCUR? Exicure has lower revenue, but higher earnings than LakeShore Biopharma. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLakeShore Biopharma$672.27M0.01-$61.09MN/AN/AExicureN/AN/A-$9.70M-$3.82-1.68 Is LSB or XCUR more profitable? LakeShore Biopharma's return on equity of 0.00% beat Exicure's return on equity.Company Net Margins Return on Equity Return on Assets LakeShore BiopharmaN/A N/A N/A Exicure N/A -353.47%-96.50% Which has more volatility and risk, LSB or XCUR? LakeShore Biopharma has a beta of 0.58, suggesting that its stock price is 42% less volatile than the S&P 500. Comparatively, Exicure has a beta of 3.57, suggesting that its stock price is 257% more volatile than the S&P 500. Does the media prefer LSB or XCUR? In the previous week, Exicure had 2 more articles in the media than LakeShore Biopharma. MarketBeat recorded 3 mentions for Exicure and 1 mentions for LakeShore Biopharma. Exicure's average media sentiment score of 0.20 beat LakeShore Biopharma's score of 0.00 indicating that Exicure is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LakeShore Biopharma 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Exicure 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral SummaryExicure beats LakeShore Biopharma on 5 of the 9 factors compared between the two stocks. Get LakeShore Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for LSB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LSB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LSB vs. The Competition Export to ExcelMetricLakeShore BiopharmaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$9.23M$2.88B$5.50B$9.01BDividend YieldN/A2.43%5.38%4.04%P/E RatioN/A21.5627.6020.30Price / Sales0.01172.94369.09103.84Price / CashN/A41.9536.6357.47Price / Book0.117.518.055.68Net Income-$61.09M-$55.05M$3.18B$249.13M7 Day Performance7.96%4.61%2.82%3.30%1 Month Performance-5.51%4.89%3.70%5.20%1 Year PerformanceN/A5.84%35.41%21.38% LakeShore Biopharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LSBLakeShore Biopharma0.3685 of 5 stars$0.99-2.7%N/AN/A$9.23M$672.27M0.00773Positive NewsGap UpXCURExicure2.0083 of 5 stars$5.72-12.0%N/A+1,941.3%$36.15M$500K-1.1950Earnings ReportEGRXEagle PharmaceuticalsN/A$2.75-1.4%N/A-45.5%$35.71M$257.55M0.00100Gap DownELYMEliem TherapeuticsN/A$1.20-0.8%N/A-81.6%$35.70MN/A-2.269ABVCABVC BioPharma0.5147 of 5 stars$2.06+5.1%N/A+315.1%$34.98M$510K-15.8530News CoverageLVTXLAVA Therapeutics1.8674 of 5 stars$1.33+0.1%$3.17+138.8%-25.8%$34.89M$11.98M-1.2860ESLAEstrella Immunopharma2.2514 of 5 stars$0.96+4.3%$16.00+1,566.7%-19.7%$34.72MN/A-3.69N/AGap UpLTRNLantern Pharma2.5094 of 5 stars$3.21+4.6%$25.00+678.8%-25.9%$34.62MN/A-1.7420News CoverageGap DownPLURPluri3.6127 of 5 stars$4.42+0.7%$12.00+171.5%+2.1%$34.61M$330K-0.80150News CoveragePositive NewsInsider TradeOKUROnKure Therapeutics2.7327 of 5 stars$2.56+6.2%$32.33+1,163.0%N/A$34.59MN/A-0.49N/AXLOXilio Therapeutics2.7713 of 5 stars$0.66-1.4%$4.00+505.7%-19.7%$34.20M$6.34M-0.7970News CoveragePositive News Related Companies and Tools Related Companies Exicure Competitors Eagle Pharmaceuticals Competitors Eliem Therapeutics Competitors ABVC BioPharma Competitors LAVA Therapeutics Competitors Estrella Immunopharma Competitors Lantern Pharma Competitors Pluri Competitors OnKure Therapeutics Competitors Xilio Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LSB) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersElon’s RevengeElon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is th...Altimetry | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTop Picks for Trump’s Pro-Crypto AmericaMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LakeShore Biopharma Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share LakeShore Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
